Open access peer-reviewed chapter

Clinical Implications of Genetic Admixture in Hispanic Puerto Ricans: Impact on the Pharmacogenetics of CYP2C19 and PON1

By Jorge Duconge, Odalys Escalera, Mohan Korchela and Gualberto Ruaño

Submitted: March 1st 2011Reviewed: August 5th 2011Published: March 21st 2012

DOI: 10.5772/28567

Downloaded: 1846

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Jorge Duconge, Odalys Escalera, Mohan Korchela and Gualberto Ruaño (March 21st 2012). Clinical Implications of Genetic Admixture in Hispanic Puerto Ricans: Impact on the Pharmacogenetics of CYP2C19 and PON1, Clinical Applications of Pharmacogenetics Despina Sanoudou, IntechOpen, DOI: 10.5772/28567. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/clinical-applications-of-pharmacogenetics/clinical-implications-of-genetic-admixture-in-hispanic-puerto-ricans-impact-on-the-pharmacogenetics-" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1846total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Neuropharmacogenetics of Major Depression: Has the Time Come to Take both Sexes into Account?

By Pothitos M. Pitychoutis, Despina Sanoudou, Christina Dalla and Zeta Papadopoulou-Daifoti

Related Book

First chapter

Metabotropic Receptors for Glutamate and GABA

By Gregory Stewart, Julie Kniazeff, Laurent Prézeau, Philippe Rondard, Jean-Philippe Pin and Cyril Goudet

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us